title: Fluorescence imaging agents in cancerology.
abstract: BACKGROUND
  One of the major challenges in cancer therapy is to improve early detection and prevention using novel targeted cancer diagnostics. Detection requests specific recognition. Tumor markers have to be ideally present on the surface of cancer cells. Their targeting with ligands coupled to imaging agents make them visible/detectable.
  
  
  CONCLUSIONS
  Fluorescence imaging is a newly emerging technology which is becoming a complementary medical method for cancer diagnosis. It allows detection with a high spatio-temporal resolution of tumor markers in small animals and in clinical studies. In this review, we focus on the recent outcome of basic studies in the design of new approaches (probes and devices) used to detect tumor cells by fluorescence imaging.
authors.affiliation: CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale); Toulouse, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Paganin-Gioanni
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Bellard
authors.forename: Laurent
authors.initials: L
authors.lastname: Paquereau
authors.forename: Vincent
authors.initials: V
authors.lastname: Ecochard
authors.forename: Muriel
authors.initials: M
authors.lastname: Golzio
authors.forename: Justin
authors.initials: J
authors.lastname: Teissié